Ju, Z.; Su, M.; Li, D.; Hong, J.; Im, D.-S.; Kim, S.; Kim, E.L.; Jung, J.H.
An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway. Mar. Drugs 2019, 17, 321.
https://doi.org/10.3390/md17060321
AMA Style
Ju Z, Su M, Li D, Hong J, Im D-S, Kim S, Kim EL, Jung JH.
An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway. Marine Drugs. 2019; 17(6):321.
https://doi.org/10.3390/md17060321
Chicago/Turabian Style
Ju, Zhiran, Mingzhi Su, Dandan Li, Jongki Hong, Dong-Soon Im, Suhkmann Kim, Eun La Kim, and Jee H. Jung.
2019. "An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway" Marine Drugs 17, no. 6: 321.
https://doi.org/10.3390/md17060321
APA Style
Ju, Z., Su, M., Li, D., Hong, J., Im, D. -S., Kim, S., Kim, E. L., & Jung, J. H.
(2019). An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway. Marine Drugs, 17(6), 321.
https://doi.org/10.3390/md17060321